- Home
- AVTX vs AEF Comparison
AVTX vs AEF Comparison
Compare AVTX & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | AEF |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.9M | 351.6M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | AEF |
|---|---|---|
| Price | $17.10 | $7.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $32.57 | N/A |
| AVG Volume (30 Days) | ★ 510.9K | 183.9K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.13% |
| EPS Growth | ★ 81.66 | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.63 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $3.39 | $4.43 |
| 52 Week High | $20.72 | $8.93 |
Technical Indicators
Market Signals| Indicator | AVTX | AEF |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 43.02 |
| Support Level | $15.36 | $7.64 |
| Resistance Level | $19.26 | $8.09 |
| Average True Range (ATR) | 1.36 | 0.23 |
| MACD | 0.07 | -0.13 |
| Stochastic Oscillator | 65.50 | 28.29 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.